Conference · Arlington, Virginia
CHI’S Translational Cancer Medicine 2010
Health · Medicine · Pharmaceuticals
Key numbers
- Editions on record
- 5first in 2009
About CHI’S Translational Cancer Medicine
Research of the molecular mechanisms of cancer, which is a complex disease, has recently benefitted from advanced “omic” and cellular technologies, providing scientists with new opportunities for diagnostic and therapeutic development. The Translational Cancer Medicine track of ADAPT 2010 Congress focuses on three of these opportunities: 1. Using circulating tumor cells as markers for disease prognosis and treatment selection; 2. Understanding cancer stem cell mechanism toward development of novel therapeutics; and 3. Extracting novel targets and biomarkers from the cancer genome.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2012 | 19–21 Sep 2012 | Renaissance Washington D C Hotel Downtown Washington, District of Columbia | — | — |
| 2011 | 24–25 Sep 2011 | Chicago Market Chicago, Illinois | — | — |
| 2010 | 13–16 Sep 2010 | Hyatt Regency Crystal City Arlington, Virginia | — | — |
| 2010 | 15 Jan 2010 | — | — | |
| 2009 | 26–28 Jan 2009 | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.